ARRS State of the Art Imaging for Chronic Liver Disease 2021

Intengo ejwayelekile: $45.00
Intengo yokuthengiswa: $45.00
Intengo ejwayelekile
Intengo yokukodwa: ngayinye

I-ARRS State of the Art Imaging yeSifo Sesibindi Esingapheli 2021

4 Amavidiyo , Usayizi Wesifundo = 234.00 MB

by I-American Roentgen Ray Society

UZOTHOLA ISIFUNDO NGE I-LIFETIME DOWNLOAD LINK (ISHESHAYO) NGEMVA KOKUKHOKHWA

Isizathu sesibili esihamba phambili sokufa okuhlobene nomdlavuza emhlabeni kanye nesizathu sesithathu esivame kakhulu sokufa phakathi kweziguli ezine-cirrhosis, i-hepatocellular carcinoma (HCC) ikhula ngezinga elilinganayo elingaguquki-cishe ama-3% ngonyaka, kungakhathaliseki ukuthi i-cirrhotic stage. Lesi sifundo se-Online Course sihlanganisa ukutholakala kwezifo zesibindi ezisabalalisiwe ezivame ukuphumela ku-HCC, kanye nezingibe ezihlukahlukene kanye nokulingisa okuholela ekuhumusheni kabi.

Imiphumela yokufunda kanye nezinkulumo

Ngemuva kokuphothula le nkambo, umfundi kufanele akwazi:

Chaza isibuyekezo samanje se-Imaging sezifo zesibindi ezisakazekile.
Xoxa ngokuvela kwe-LI-RADS ngokwenza kwamanje kanye nemibono yesikhathi esizayo.
Bonisa izingibe ezihlukahlukene kanye nokulingisa okungavimbela ukuhlonzwa kokubhekwa ku-cirrhosis.
Xoxa ngokusetshenziswa kwe-Gadoxetate Disodium ezigulini ezine-cirrhosis.

Izihloko Nezipikha:

Izipikha nezinkulumo

Ukufanekisa Izifo Zesibindi Ezisakazwayo—K. Fowler
I-LI-RADS: Okwedlule, Okwamanje, Nekusasa—C. Sirlin
Izingibe kanye Nokuxilongwa Okungalungile ku-Cirrhosis-K. Elsayes
Ukusetshenziswa kwe-Gadoxetate disodium ezigulini ezine-Cirrhosis-V. Chernyak